Last checked at 17 Jun 2021 11:34
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | UDG HEALTHCARE PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 16 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
6,062,085 | 2.41% | 149,346 | 0.06% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
92,243 | 0.04% | 5,544,735 | 2.20% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
6,154,328 | 2.44% | 5,694,081 | 2.26% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 277 | 10.4444 GBP |
Purchase | 569 | 10.5000 GBP |
Purchase | 932 | 10.4725 GBP |
Purchase | 1,113 | 10.4655 GBP |
Purchase | 1,747 | 10.4448 GBP |
Purchase | 1,841 | 10.4400 GBP |
Purchase | 2,498 | 10.4533 GBP |
Purchase | 7,088 | 10.4994 GBP |
Purchase | 10,082 | 10.4504 GBP |
Purchase | 13,589 | 10.4512 GBP |
Purchase | 16,688 | 10.4502 GBP |
Purchase | 25,956 | 10.4550 GBP |
Purchase | 27,703 | 10.4478 GBP |
Purchase | 221,693 | 10.4744 GBP |
Purchase | 345,971 | 10.4600 GBP |
Sale | 13 | 10.4992 GBP |
Sale | 64 | 10.4500 GBP |
Sale | 1,166 | 10.4550 GBP |
Sale | 18,050 | 10.4834 GBP |
Sale | 72,888 | 10.5000 GBP |
Sale | 632,145 | 10.4636 GBP |
(b) Derivatives transactions (other than options transactions)
Product Name | Nature of transaction | Number of relevant securities | Price per |
|
|
| unit |
CFD | Long | 6 | 10.5000 GBP |
CFD | Long | 7 | 10.4985 GBP |
SWAP | Long | 1,163 | 10.4509 GBP |
SWAP | Long | 3,886 | 10.5000 GBP |
SWAP | Long | 4,776 | 10.4488 GBP |
SWAP | Long | 8,289 | 10.4998 GBP |
SWAP | Short | 2,330 | 10.4710 GBP |
SWAP | Short | 4,520 | 10.4500 GBP |
SWAP | Short | 10,565 | 10.4640 GBP |
SWAP | Short | 23,855 | 10.4590 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 17 Jun 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210617005425/en/
Copyright Business Wire 2021